About the article
Yu Zhu is a MD candidate at the Zhejiang University School of Medicine. He is engaged in clinical and research work in neurosurgery, especially in the treatment for cerebral vascular disease and cerebral tumor. His thesis work focused on stem cell therapies for ischemic stroke and etiology of cerebral glioma.
Shu Wan, PhD, MD, is an Associate Professor at the Department of Neurosurgery, The First Affiliated Hospital, School of Medicine, Zhejiang University. He received his MD degree in 1997 and did his PhD at the Zhejiang University School of Medicine. From June 2004 to October 2005 he continued his clinical training and research as a visiting scholar at the University of Michigan (in Ann Arbor), USA. His present clinical practice and research work focuses on cerebral vascular disease.
Prof. Ren-ya Zhan, PhD, MD, is the Director of the Department of Neurosurgery, The First Affiliated Hospital, School of Medicine, Zhejiang University. He graduated from Zhe jiang University School of Medicine and received a MD degree in 1983, he did his PhD in Kiel University, Germany in 1998–2002. He has been constantly engaged in both preclinical and clinical research of cerebral vascular disease, cerebral tumor and severe craniocerebral trauma. He also leads a series of research teams investigating endogenous neural stem cells’ applicatory potential for ischemic stroke and the role of liposome in formation of glioma.
Published Online: 2012-06-24
Published in Print: 2012-08-01